CLINICAL_TRIALS
trial_result
· 2015-06-03
Clinical Trial Update: A Degarelix Trial in Patients With Prostate Cancer [Phase 3]
Summary
A Phase 3 trial of degarelix in prostate cancer was terminated, and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2015-06-03